Literature DB >> 318940

Serum albumin: recent progress in the understanding of its structure and biosynthesis.

T Peters.   

Abstract

Major discoveries have been made in the past few years on the structure and mode of biosynthesis of serum albumin. The complete amino acid sequence of this protein has been determined, and its covalent structure shown to be a single peptide chain grouped into a series of nine disulfide-bonded loops. These loops appear to associate into three similar domains. By study of isolated fragments of the molecule it can be demonstrated that the binding of billirubin and the primary binding of long-chain fatty acids are functions of separate domains. The biosynthesis of albumin has been found to involve a precursor form, termed "proalbumin", in which a basic hexapeptide is attached to the amino end of the chain. Similar precursor forms are now known to have a role in the formation of other secreted proteins, but in the case of albumin the purpose of the additional peptide is not clear. Clinical methodology for albumin assay has advanced but little despite--or perhaps in part because of--the increasing use of automation. Hope for improvement is foreseen in the advent of immunochemical procedures and in a better understanding of the specificity of dye-binding reactions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 318940

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  32 in total

1.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

2.  Amphibian albumins as members of the albumin, alpha-fetoprotein, vitamin D-binding protein multigene family.

Authors:  D N Haefliger; J E Moskaitis; D R Schoenberg; W Wahli
Journal:  J Mol Evol       Date:  1989-10       Impact factor: 2.395

3.  Synthesis and copper(II)-binding properties of the N-terminal peptide of human alpha-fetoprotein.

Authors:  S J Lau; J P Laussac; B Sarkar
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

4.  Relations between high-affinity binding sites of markers for binding regions on human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

5.  Identification of a 130-kDa albumin in tuatara (Sphenodon) and detection of a novel albumin polymorphism.

Authors:  M A Brown; A Carne; C H Daugherty; G K Chambers
Journal:  Biochem Genet       Date:  1995-06       Impact factor: 1.890

6.  The sequence of human serum albumin cDNA and its expression in E. coli.

Authors:  R M Lawn; J Adelman; S C Bock; A E Franke; C M Houck; R C Najarian; P H Seeburg; K L Wion
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

7.  Binding of digitoxin, digoxin and gitoxin to human serum albumin.

Authors:  J P Tillement; R Zini; M Lecomte; P d'Athis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

8.  CD36 mediates albumin transcytosis by dermal but not lung microvascular endothelial cells: role in fatty acid delivery.

Authors:  Hira Raheel; Siavash Ghaffari; Negar Khosraviani; Victoria Mintsopoulos; Derek Auyeung; Changsen Wang; Yun Hye Kim; Brendan Mullen; Hoon-Ki Sung; May Ho; Gregory Fairn; Dante Neculai; Maria Febbraio; Bryan Heit; Warren L Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

9.  Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.

Authors:  R Zini; D Morin; C Salvadori; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

10.  Chemical characterization of human urine albumin in proteinuria.

Authors:  B A Lang; L Morávek; B Meloun
Journal:  Experientia       Date:  1979-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.